Danimer Scientific, Inc.
DNMR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $46,684 | $53,218 | $58,749 | $47,333 |
| % Growth | -12.3% | -9.4% | 24.1% | – |
| Cost of Goods Sold | $73,644 | $63,632 | $57,865 | $35,876 |
| Gross Profit | -$26,960 | -$7,908 | $884 | $11,457 |
| % Margin | -57.7% | -14.9% | 1.5% | 24.2% |
| R&D Expenses | $29,242 | $31,939 | $20,270 | $7,851 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $68,983 | $81,589 | $80,004 | $19,343 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $434 | $65,998 | $0 | $0 |
| Operating Expenses | $98,659 | $179,526 | $100,274 | $27,194 |
| Operating Income | -$125,619 | -$187,434 | -$99,390 | -$15,737 |
| % Margin | -269.1% | -352.2% | -169.2% | -33.2% |
| Other Income/Exp. Net | -$29,535 | $6,866 | $26,132 | $6,875 |
| Pre-Tax Income | -$155,154 | -$180,568 | -$73,340 | -$8,853 |
| Tax Expense | $319 | -$810 | -$13,233 | $0 |
| Net Income | -$155,473 | -$179,758 | -$60,107 | -$8,853 |
| % Margin | -333% | -337.8% | -102.3% | -18.7% |
| EPS | -1.52 | -1.78 | -0.65 | -0.1 |
| % Growth | 14.6% | -173.8% | -550% | – |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.1 |
| Weighted Avg Shares Out | 102,002 | 101,095 | 93,078 | 84,536 |
| Weighted Avg Shares Out Dil | 102,002 | 101,095 | 93,078 | 84,536 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $347 |
| Interest Expense | $29,641 | $1,723 | $763 | $2,427 |
| Depreciation & Amortization | $29,058 | $20,086 | $11,674 | $4,609 |
| EBITDA | -$96,127 | -$103,489 | -$87,716 | -$1,817 |
| % Margin | -205.9% | -194.5% | -149.3% | -3.8% |